Wafergen Bio-systems (WGBS) Narrows Q3 Loss

Wafergen Bio-systems (NASDAQ: WGBS) reported Q3 EPS of ($1.32), versus ($43.51) reported last year. Revenue for the quarter came in at $1.3 million, versus $389 thousand reported last year.

For earnings history and earnings-related data on Wafergen Bio-systems (WGBS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group